Apollomics, Inc. logo

APLMApollomics, Inc.

APLM Stock Price, Valuation & Chart | Apollomics, Inc.

Compare

APLM Historical price chart

APLM Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization60.05M
PE Ratio-3.61
EPS-7.57
Trading Volume11.64K
Today's High/Low28.0/26.3
Dividend Yield0.00
52 Week High/Low42.12/3.95
Shares Outstanding2.20M
APLM Financial Statement
APLM Analyst ratings
APLM Analysis & performance metrics

APLM Company profile

Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai,…

APLM Management team

Management
Sanjeev Redkar MBA, Ph.D.CTO
Co-Founder & Executive Director
Matthew James Plunkett Ph.D.CFO
Chief Financial Officer
Guo-Liang Yu Ph.D.CEO
Co-Founder, Chief Executive Officer & Executive Chairman
Total 3 executives

APLM Frequently asked questions

What is Apollomics, Inc. (APLM) Stock Price?

Current stock price of Apollomics, Inc. (APLM) stock is $27.350. The stock price is +1.51% higher in the session. The intraday range can be seen from this page. Volume of Apollomics, Inc. (APLM) stock is 11.64K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Apollomics, Inc. (APLM) stock price going up or down today?

The stock price of Apollomics, Inc. (APLM) can change with earnings, company news, and overall market sentiment. Apollomics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Apollomics, Inc. stock expensive at its current price?

Whether Apollomics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for APLM on this page is -3.61. EPS on this page is -7.57. Compare those figures with peers and growth expectations before deciding if the current Apollomics, Inc. price is justified.

How has the stock price of Apollomics, Inc. (APLM) performed historically?

Historical performance for Apollomics, Inc. (APLM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how APLM reacted to past earnings and market events.

Should I buy Apollomics, Inc. (APLM) stock, at this price?

Buying Apollomics, Inc. (APLM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.